Inventor · disambiguated record
Philipp Hadwiger
Also filed as: HADWIGER PHILIPP
51 granted patents·15 pending applications·1,820 citations·filing 2003–2023
99Inventor score
Files withALNYLAM PHARMACEUTICALS INC25AXOLABS GMBH4HADWIGER PHILIPP4HOFFMANN LA ROCHE4MPEG LA L L C4
Top patents by PatentIndex Score
66 records- 0199US7749978B2Compositions and methods for inhibiting expression of Huntingtin geneALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Jul 6, 2010·113 cites·26 claims
- 0299US7582745B2Compositions and methods for inhibiting expression of Nav1.8 geneALNYLAM PHARMACEUTICALS INC·Filed 2006·Granted Sep 1, 2009·152 cites·11 claims
- 0399US7320965B2Compositions and methods for inhibiting expression of Huntingtin geneALNYLAM PHARMACEUTICALS INC·Filed 2006·Granted Jan 22, 2008·208 cites·8 claims
- 0498US8501930B2Peptide-based in vivo siRNA delivery systemROZEMA DAVID B·Filed 2011·Granted Aug 6, 2013·180 cites·18 claims
- 0598US7737265B2RNAi modulation of HIF-1 and therapeutic uses thereofALNYLAM PHARMACEUTICALS INC·Filed 2006·Granted Jun 15, 2010·122 cites·27 claims
- 0696US9433681B2Lipids and compositions for intracellular delivery of biologically active compoundsAXOLABS GMBH·Filed 2014·Granted Sep 6, 2016·24 cites·21 claims
- 0796US8546143B2Compositions and methods for inhibiting expression of a target geneKREUTZER ROLAND·Filed 2010·Granted Oct 1, 2013·47 cites·18 claims
- 0896US8334373B2Nuclease resistant double-stranded ribonucleic acidVORNLOCHER HANS-PETER·Filed 2011·Granted Dec 18, 2012·30 cites·22 claims
- 0996US7947659B2iRNA agents targeting VEGFALNYLAM PHARMACEUTICALS INC·Filed 2005·Granted May 24, 2011·26 cites·10 claims
- 1096US7928217B2Nuclease resistant double-stranded ribonucleic acidALNYLAM PHARMACEUTICALS INC·Filed 2005·Granted Apr 19, 2011·37 cites·19 claims
- 1196US7919473B2IRNA agents targeting VEGFALNYLAM PHARMACEUTICALS INC·Filed 2006·Granted Apr 5, 2011·29 cites·7 claims
- 1296US7829693B2Compositions and methods for inhibiting expression of a target geneALNYLAM PHARMACEUTICALS INC·Filed 2003·Granted Nov 9, 2010·134 cites·6 claims
- 1395US9796756B2Galactose cluster-pharmacokinetic modulator targeting moiety for siRNAARROWHEAD MADISON INC·Filed 2015·Granted Oct 24, 2017·24 cites·20 claims
- 1495US8802773B2In vivo polynucleotide delivery conjugates having enzyme sensitive linkagesROZEMA DAVID B·Filed 2013·Granted Aug 12, 2014·12 cites·22 claims
- 1595US8691750B2Lipids and compositions for intracellular delivery of biologically active compoundsCONSTIEN RAINER·Filed 2012·Granted Apr 8, 2014·288 cites·13 claims
- 1695US8426554B2In vivo polynucleotide delivery conjugates having enzyme sensitive linkagesROZEMA DAVID B·Filed 2011·Granted Apr 23, 2013·47 cites·14 claims
- 1795US7786290B2Double-stranded ribonucleic acid with increased effectiveness in an organismALNYLAM PHARMACEUTICALS INC·Filed 2004·Granted Aug 31, 2010·99 cites·31 claims
- 1894US9278130B2Lipids and compositions for intracellular delivery of biologically active compoundsAXOLABS GMBH·Filed 2014·Granted Mar 8, 2016·15 cites·20 claims
- 1994US7528118B2RNAi modulation of ApoB and uses thereofALNYLAM PHARMACEUTICALS INC·Filed 2005·Granted May 5, 2009·21 cites·22 claims
- 2093US10131907B2Glycoconjugates of RNA interference agentsALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Nov 20, 2018·11 cites·26 claims
- 2192US9636302B2Lipids and compositions for intracellular delivery of biologically active compoundsAXOLABS GMBH·Filed 2016·Granted May 2, 2017·6 cites·22 claims
- 2292US8877917B2Glycoconjugates of RNA interference agentsFORST ANDREA·Filed 2008·Granted Nov 4, 2014·44 cites·15 claims
- 2391US11767531B2Defined multi-conjugates oligonucleotidesMPEG LA L L C·Filed 2022·Granted Sep 26, 2023·2 cites·18 claims
- 2491US8293719B2iRNA agents targeting VEGFDE FOUGEROLLES ANTONIN·Filed 2011·Granted Oct 23, 2012·11 cites·25 claims
- 2591US7361752B2RNAi modulation of MLL-AF4 and uses thereofALNYLAM PHARMACEUTICALS INC·Filed 2005·Granted Apr 22, 2008·14 cites·7 claims
- 2689US8034793B2RNAi modulation of MLL-AF4 and uses thereofALNYLAM PHARMACEUTICALS INC·Filed 2010·Granted Oct 11, 2011·10 cites·30 claims
- 2788US7994307B2RNAi modulation of the BCR-ABL fusion gene and uses thereofALNYLAM PHARMACEUTICALS INC·Filed 2009·Granted Aug 9, 2011·8 cites·15 claims
- 2888US7473525B2Compositions and methods for inhibiting expression of anti-apoptotic genesALNYLAM EUROPE AG·Filed 2003·Granted Jan 6, 2009·53 cites·4 claims
- 2987US11078484B2Multimeric oligonucleotides having decreased kidney clearanceMPEG LA LLC·Filed 2018·Granted Aug 3, 2021·4 cites·44 claims
- 3087US7674779B2RNAi modulation of MLL-AF4 and uses thereofALNYLAM PHARMACEUTICALS INC·Filed 2008·Granted Mar 9, 2010·5 cites·19 claims
- 3186US9011919B2Compositions for targeted delivery of siRNAROZEMA DAVID B·Filed 2012·Granted Apr 21, 2015·7 cites·22 claims
- 3284US9249179B2Galactose cluster-pharmacokinetic modulator targeting moiety for siRNAHADWIGER PHILIPP·Filed 2011·Granted Feb 2, 2016·10 cites·5 claims
- 3383US9301990B2Small molecule conjugates for intracellular delivery of biologically active compoundsHOFFMANN LA ROCHE·Filed 2013·Granted Apr 5, 2016·2 cites·6 claims
- 3483US9107957B2Peptide-based in vivo siRNA delivery systemARROWHEAD MADISON INC·Filed 2013·Granted Aug 18, 2015·5 cites·14 claims
- 3583US8993746B2Nuclease resistant double-stranded ribonucleic acidVORNLOCHER HANS-PETER·Filed 2012·Granted Mar 31, 2015·3 cites·10 claims
- 3682US11352629B2Defined multi-conjugate oligonucleotidesMPEG LA LLC·Filed 2016·Granted Jun 7, 2022·2 cites·10 claims
- 3782US7906484B2Complex for transferring an anionic substance into a cellALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Mar 15, 2011·3 cites·20 claims
- 3881US8080532B2Compositions and methods for inhibiting expression of Huntingtin geneSAH DINAH WEN-YEE·Filed 2009·Granted Dec 20, 2011·2 cites·24 claims
- 3980US9968647B2Small molecule conjugates for intracellular delivery of biologically active compoundsHOFFMANN LA ROCHE·Filed 2016·Granted May 15, 2018·1 cites·3 claims
- 4079US9587240B2Compositions and methods for inhibiting expression of a target geneALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Mar 7, 2017·2 cites·20 claims
- 4178US9198947B2Small molecule conjugates for intracellular delivery of nucleic acidsHOFFMANN LA ROCHE·Filed 2013·Granted Dec 1, 2015·1 cites·5 claims
- 4276US9074213B2Compositions and methods for inhibiting expression of a target geneALNYLAM PHARMACEUTICALS INC·Filed 2013·Granted Jul 7, 2015·2 cites·15 claims
- 4376US2024191240A1Defined multi-conjugates oligonucleotidesMPEG LA L L C·Filed 2023·Application pending·0 cites
- 4475US8188061B2RNAi modulation of APOB and uses thereofSOUTSCHEK JUERGEN·Filed 2010·Granted May 29, 2012·2 cites·25 claims
- 4575US7902168B2Compositions and methods for inhibiting expression of Nav1.8 geneALNYLAM PHARMACEUTICALS INC·Filed 2009·Granted Mar 8, 2011·1 cites·11 claims
- 4671US10316316B2Compositions for targeted delivery of siRNAARROWHEAD PHARMACEUTICALS INC·Filed 2016·Granted Jun 11, 2019·1 cites·13 claims
- 4769US7723317B2RNAi modulation of ApoB and uses thereofALNYLAM PHARMACEUTICALS INC·Filed 2009·Granted May 25, 2010·0 cites·10 claims
- 4868US12378551B2Multimeric oligonucleotides having decreased kidney clearanceMPEG LA L L C·Filed 2021·Granted Aug 5, 2025·0 cites·19 claims
- 4968US9149531B2Lipids and compositions for intracellular delivery of biologically active compoundsAXOLABS GMBH·Filed 2014·Granted Oct 6, 2015·0 cites·4 claims
- 5065US9187747B2RNAi modulation of ApoB and uses thereofALNYLAM PHARMACEUTICALS INC·Filed 2013·Granted Nov 17, 2015·0 cites·21 claims
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Philipp Hadwiger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →